Detailed analysis and meaningful insight from industry experts.
Average trading multiples for U.S.-focused operators compressed this week, while Canada-focused operators still trade at a premium on sales compared to U.S. operators, despite a smaller market and lower margins.
Florida cannabis market data remained relatively stable through the week of March 5, with no major trend shifts or reversals to note. But we’ve added new analysis for you.
Cannabis companies – both marijuana and hemp – were heating up the headlines this week. From Canada to Colorado and beyond, execs made big announcements and companies shifted gears.
Curaleaf is not likely to be content with BlueKudu’s current $2.7 million in sales given its the company’s pro forma revenue guidance of $1.0 billion to $1.2 billion.
New Canopy Growth CEO David Klein is already imposing discipline upon the Canadian market by closing a staggering 58% of the Ontario company’s existing indoor production capacity and 29% of its total production area.
Looking at the data for total milligrams sold in the Florida cannabis space for the past four weeks, Trulieve continued its dominance with 51.5% market share in the state.
These comp tables provide a benchmark for private investors to evaluate existing and future investments, a way for companies to judge their own valuations for current and future capital raises as well as a menu for public investors to peruse.
These comp tables provide a benchmark for private investors to evaluate existing and future investments, a way for companies to judge their own valuations for current and future capital raises as well as a menu for public investors to peruse.
Marijuana in smoking form is the most popular method of consuming THC in Florida, accounting for approximately 65% of consumption (measured in milligrams of THC).
Denver-based Medicine Man Technologies reduced its pro forma revenue guidance but maintained its pro forma margin and EBITDA guidance via a new presentation filed with the SEC that outlines the story and the vision of the company – including a new name.
Colorado reports medical, recreational and total marijuana dollar sales on a monthly basis. One caveat to note is that the data lags six to eight weeks, so it cannot be used as a real-time measure.
These comp tables provide a benchmark for private investors to evaluate existing and future investments, a way for companies to judge their own valuations for current and future capital raises as well as a menu for public investors to peruse.
